Kestra Non Current Assets Total from 2010 to 2026

KMTS Stock   24.39  2.13  8.03%   
Kestra Medical Non Current Assets Total yearly trend continues to be comparatively stable with very little volatility. Non Current Assets Total are likely to outpace its year average in 2026. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2010-12-31
Previous Quarter
46.5 M
Current Value
48.8 M
Quarterly Volatility
17.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Kestra Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kestra Medical's main balance sheet or income statement drivers, such as Tax Provision of 81.4 K, Depreciation And Amortization of 5.6 M or Interest Expense of 4.6 M, as well as many indicators such as Price To Sales Ratio of 21.77, Dividend Yield of 0.0013 or PTB Ratio of 6.34. Kestra financial statements analysis is a perfect complement when working with Kestra Medical Valuation or Volatility modules.
  
Build AI portfolio with Kestra Stock
Check out the analysis of Kestra Medical Correlation against competitors.

Latest Kestra Medical's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Kestra Medical Technologies over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Kestra Medical's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kestra Medical's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Kestra Non Current Assets Total Regression Statistics

Arithmetic Mean13,445,925
Geometric Mean5,093,754
Coefficient Of Variation130.58
Mean Deviation14,885,785
Median1,705,000
Standard Deviation17,557,087
Sample Variance308.3T
Range47.1M
R-Value0.85
Mean Square Error91.9T
R-Squared0.72
Significance0.000016
Slope2,951,180
Total Sum of Squares4932T

Kestra Non Current Assets Total History

202648.8 M
202546.5 M
202440.4 M
202331 M
202120.2 M
20204.3 M

About Kestra Medical Financial Statements

Kestra Medical shareholders use historical fundamental indicators, such as Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Kestra Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Kestra Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Kestra Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total46.5 M48.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Kestra Stock Analysis

When running Kestra Medical's price analysis, check to measure Kestra Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kestra Medical is operating at the current time. Most of Kestra Medical's value examination focuses on studying past and present price action to predict the probability of Kestra Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kestra Medical's price. Additionally, you may evaluate how the addition of Kestra Medical to your portfolios can decrease your overall portfolio volatility.